Brown Advisory Inc Adverum Biotechnologies, Inc. Transaction History

Brown Advisory Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$2.87 - $5.92 $30,373 - $62,651	-10,583 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$4.5 - $7.6 $22,837 - $38,570	-5,075 Reduced 32.41%	10,583 $64,000
Q2 2018 Aug 10, 2018	SELL	$5.3 - $6.9 $1,733 - $2,256	-327 Reduced 2.05%	15,658 $83,000
Q1 2018 Jun 28, 2018	BUY	$3.65 - $7.95 $58,345 - $127,080	15,985 New	15,985 $93,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.